| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.27 | 7e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.062 | 0.3 |